Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship
J. antimicrob. chemother; 70 (1), 2015
Objectives: We describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12146/12214-CARINEMO trial.
Methods: Participants were randomly selected to receive either nevirapine at 200 mg twice daily...
Alcinos, Terapia Antirretroviral de Alta Atividade/métodos, Antituberculosos/uso terapêutico, Benzoxazinas/uso terapêutico, Ciclopropanos, Infecções por HIV/terapia, Tolerância a Medicamentos, Fármacos Anti-HIV/uso terapêutico, Infecções/complicações, Nevirapina/uso terapêutico, Tuberculose/terapia, Tuberculose/complicações, Resultado do Tratamento, Moçambique